Innovac Therapeutics operates as a biotechnology company.
Innovac Therapeutics has raised $18.0M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Innovac Therapeutics's investors include Vision Plus Capital, Elikon Venture, Yunion Health Investments, TG Sino-Dragon Fund.
Innovac Therapeutics is headquartered in Cambridge, United States.
Innovac Therapeutics operates as a biotechnology company.
Innovac Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Innovac Therapeutics — Funding & Investors." VCBacked, September 1, 2023, https://www.vcbacked.co/company/innovac-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). Innovac Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/innovac-therapeutics
{{cite web |title=Innovac Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/innovac-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated